CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma.
Saved in:
| Title: | CD155 blockade enhances allogeneic natural killer cell-mediated antitumor response against osteosarcoma. |
|---|---|
| Authors: | Cho MM; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Song L; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Quamine AE; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Szewc F; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Shi L; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Ebben JD; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Turicek DP; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Kline JM; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Burpee DM; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Lafeber EO; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Phillips MF; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Ceas AS; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Bates PD; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Forsberg MH; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Kink JA; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Erbe AK; Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA., Capitini CM; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA ccapitini@pediatrics.wisc.edu.; Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Apr 15; Vol. 13 (4). Date of Electronic Publication: 2025 Apr 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
